Hematologic Oncology Update cover art

Hematologic Oncology Update

Hematologic Oncology Update

By: Dr. Neil Love
Listen for free

Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.Copyright 2025 Research To Practice. All Rights Reserved Hygiene & Healthy Living Physical Illness & Disease Science
Episodes
  • Bruton Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukemia — Year in Review Series on Relevant New Datasets and Advances

    Bruton Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukemia — Year in Review Series on Relevant New Datasets and Advances
    May 23 2026

    Dr Jennifer R Brown and Prof Wojciech Jurczak discuss the selection and sequencing of Bruton tyrosine kinase-targeted therapy for patients with chronic lymphocytic leukemia and summarize major advances in the treatment landscape over the past year.

    CME information and select publications here.
    Show More Show Less
    59 mins
  • Acute Myeloid Leukemia — Year in Review Series on Relevant New Datasets and Advances

    Acute Myeloid Leukemia — Year in Review Series on Relevant New Datasets and Advances
    Apr 20 2026

    Dr Amir Fathi from Massachusetts General Hospital in Boston, Massachusetts, and Dr Eunice S Wang from Roswell Park Comprehensive Cancer Center in Buffalo, New York, discuss key clinical trial data surrounding the use of menin inhibitors in the management of AML.

    CME information and select publications here.
    Show More Show Less
    59 mins
  • CELMoDs for Multiple Myeloma — Microlearning Activity 2 with Dr Paul G Richardson

    CELMoDs for Multiple Myeloma — Microlearning Activity 2 with Dr Paul G Richardson
    Apr 10 2026

    Dr Paul G Richardson from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses how CELMoDs function, available data with these agents and their possible future role in the treatment of multiple myeloma.

    CME information and select publications here.
    Show More Show Less
    25 mins
adbl_web_anon_alc_button_suppression_c
No reviews yet